238 related articles for article (PubMed ID: 27906678)
1. Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia.
Griggio V; Mandili G; Vitale C; Capello M; Macor P; Serra S; Castella B; Peola S; Foglietta M; Drandi D; Omedé P; Sblattero D; Cappello P; Chiarle R; Deaglio S; Boccadoro M; Novelli F; Massaia M; Coscia M
Oncotarget; 2017 Jan; 8(2):3274-3288. PubMed ID: 27906678
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune responses against the immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia.
Friedrichs B; Siegel S; Kloess M; Barsoum A; Coggin J; Rohrer J; Jakob I; Tiemann M; Heidorn K; Schulte C; Kabelitz D; Steinmann J; Schmitz N; Zeis M
J Immunol; 2008 May; 180(9):6374-84. PubMed ID: 18424761
[TBL] [Abstract][Full Text] [Related]
3. Alpha-Enolase (
Cappello P; Principe M; Bulfamante S; Novelli F
Front Biosci (Landmark Ed); 2017 Jan; 22(5):944-959. PubMed ID: 27814656
[TBL] [Abstract][Full Text] [Related]
4. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
Scrivener S; Goddard RV; Kaminski ER; Prentice AG
Leuk Lymphoma; 2003 Mar; 44(3):383-9. PubMed ID: 12688308
[TBL] [Abstract][Full Text] [Related]
5. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
6. Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins.
Sanchez TW; Zhang G; Li J; Dai L; Mirshahidi S; Wall NR; Yates C; Wilson C; Montgomery S; Zhang JY; Casiano CA
Mol Cell Proteomics; 2016 Dec; 15(12):3564-3580. PubMed ID: 27742740
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia.
Hojjat-Farsangi M; Jeddi-Tehrani M; Daneshmanesh AH; Mozaffari F; Moshfegh A; Hansson L; Razavi SM; Sharifian RA; Rabbani H; Österborg A; Mellstedt H; Shokri F
PLoS One; 2015; 10(11):e0142310. PubMed ID: 26562161
[TBL] [Abstract][Full Text] [Related]
8. Treponema denticola enolase contributes to the production of antibodies against ENO1 but not to the progression of periodontitis.
Lee A; Kim YC; Baek K; Alam J; Choi YS; Rheu Y; Shin YJ; Kim S; Kim HD; Song YW; Choi Y
Virulence; 2018; 9(1):1263-1272. PubMed ID: 30001173
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
10. SEMG-1 expression in early stage chronic lymphocytic leukemia.
Ahmed SU; Meklat F; Shahriar M; Zhang J; Mastulov S; Giannakouros T; Jewell A; Zhang Y; Lim SH
Cytotherapy; 2009; 11(2):238-44. PubMed ID: 19241194
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylated alpha-enolase induces autoantibodies in HLA-DR8 pancreatic cancer patients and triggers HLA-DR8 restricted T-cell activation.
Capello M; Caorsi C; Bogantes Hernandez PJ; Dametto E; Bertinetto FE; Magistroni P; Rendine S; Amoroso A; Novelli F
Immunol Lett; 2015 Sep; 167(1):11-6. PubMed ID: 26096821
[TBL] [Abstract][Full Text] [Related]
12. Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia.
Alfonso-Pérez M; López-Giral S; Quintana NE; Loscertales J; Martín-Jiménez P; Muñoz C
J Leukoc Biol; 2006 Jun; 79(6):1157-65. PubMed ID: 16603585
[TBL] [Abstract][Full Text] [Related]
13. Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens.
Marina O; Hainz U; Biernacki MA; Zhang W; Cai A; Duke-Cohan JS; Liu F; Brusic V; Neuberg D; Kutok JL; Alyea EP; Canning CM; Soiffer RJ; Ritz J; Wu CJ
Cancer Res; 2010 Feb; 70(4):1344-55. PubMed ID: 20124481
[TBL] [Abstract][Full Text] [Related]
14. Anti-α-enolase is a prognostic marker in postoperative lung cancer patients.
Hsiao KC; Shih NY; Chu PY; Hung YM; Liao JY; Chou SW; Yang YY; Chang GC; Liu KJ
Oncotarget; 2015 Oct; 6(33):35073-86. PubMed ID: 26551021
[TBL] [Abstract][Full Text] [Related]
15. B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha.
Rosati E; Sabatini R; Tabilio A; Di Ianni M; Bartoli A; Marconi P
Leuk Res; 2005 Jul; 29(7):829-39. PubMed ID: 15927678
[TBL] [Abstract][Full Text] [Related]
16. Enhancing the action of rituximab in chronic lymphocytic leukemia by adding fresh frozen plasma: complement/rituximab interactions & clinical results in refractory CLL.
Klepfish A; Gilles L; Ioannis K; Rachmilewitz EA; Schattner A
Ann N Y Acad Sci; 2009 Sep; 1173():865-73. PubMed ID: 19758239
[TBL] [Abstract][Full Text] [Related]
17. A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display.
Baskar S; Suschak JM; Samija I; Srinivasan R; Childs RW; Pavletic SZ; Bishop MR; Rader C
Blood; 2009 Nov; 114(20):4494-502. PubMed ID: 19667400
[TBL] [Abstract][Full Text] [Related]
18. Identification of melanoma antigens using a Serological Proteome Approach (SERPA).
Suzuki A; Iizuka A; Komiyama M; Takikawa M; Kume A; Tai S; Ohshita C; Kurusu A; Nakamura Y; Yamamoto A; Yamazaki N; Yoshikawa S; Kiyohara Y; Akiyama Y
Cancer Genomics Proteomics; 2010; 7(1):17-23. PubMed ID: 20181627
[TBL] [Abstract][Full Text] [Related]
19. Synergistic induction of apoptosis in B-cell chronic lymphocytic leukemia cells after treatment with all-trans retinoic acid in combination with interleukin-21 and rituximab.
Abbaszadeh-Goudarzi K; Shokri F; Hosseini M; Jadidi-Niaragh F; Ghalamfarsa G; Saboor-Yaraghi AA
J Cancer Res Ther; 2016; 12(4):1278-1283. PubMed ID: 28169240
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.
Hayden RE; Pratt G; Roberts C; Drayson MT; Bunce CM
Leuk Lymphoma; 2012 Apr; 53(4):537-49. PubMed ID: 21812539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
